117 related articles for article (PubMed ID: 10234330)
1. High cost of Chlamydia can be cut, researcher finds.
Silversides A
CMAJ; 1999 Apr; 160(8):1119. PubMed ID: 10234330
[No Abstract] [Full Text] [Related]
2. Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis Infections.
Andersen B; Gundgaard J; Kretzschmar M; Olsen J; Welte R; Oster-Gaard L
Sex Transm Dis; 2006 Jul; 33(7):407-15. PubMed ID: 16601656
[TBL] [Abstract][Full Text] [Related]
3. Modelling the impact of opportunistic screening on the sequelae and public healthcare costs of infection with Chlamydia trachomatis in Australian women.
Ward B; Rodger AJ; Jackson TJ
Public Health; 2006 Jan; 120(1):42-9. PubMed ID: 16271271
[TBL] [Abstract][Full Text] [Related]
4. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
Habets PC
Ned Tijdschr Geneeskd; 2001 Mar; 145(10):499-501. PubMed ID: 11268916
[No Abstract] [Full Text] [Related]
5. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
[TBL] [Abstract][Full Text] [Related]
7. Is Europe ready for STD screening?
Mårdh PA
Genitourin Med; 1997 Apr; 73(2):96-8. PubMed ID: 9215088
[No Abstract] [Full Text] [Related]
8. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
Blake DR; Gaydos CA; Quinn TC
Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
[TBL] [Abstract][Full Text] [Related]
10. The chlamydia problem in New Zealand.
Perkins N
N Z Med J; 2004 May; 117(1194):U887. PubMed ID: 15156205
[No Abstract] [Full Text] [Related]
11. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Ruitenberg EN
Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
[No Abstract] [Full Text] [Related]
12. A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home.
Novak DP; Lindholm L; Jonsson M; Karlsson RB
Scand J Public Health; 2004; 32(5):324-32. PubMed ID: 15513664
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia trachomatis genital infections--United States, 1995.
Can Commun Dis Rep; 1998 Jan; 24(1):5-8. PubMed ID: 9494223
[No Abstract] [Full Text] [Related]
14. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
Nyári T; Mészáros G; Deák J; Nagy E; Kovács L
Orv Hetil; 2000 Jul; 141(27):1511-6. PubMed ID: 10943109
[TBL] [Abstract][Full Text] [Related]
15. Screening for chlamydia in general practice.
Heal C; Jones B; Veitch C; Lamb S; Hodgens S; Browning S; Butler H; Carey M
Aust Fam Physician; 2002 Aug; 31(8):779-82. PubMed ID: 12189675
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia trachomatis: common misperceptions and misunderstandings.
Stevens-Simon C; Sheeder J
J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):231-43. PubMed ID: 16171726
[No Abstract] [Full Text] [Related]
17. [Towards screening for Chlamydia trachomatis].
Kolmos HJ
Ugeskr Laeger; 1997 Aug; 159(34):5104-5. PubMed ID: 9297316
[No Abstract] [Full Text] [Related]
18. Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project.
Robinson S; Roberts T; Barton P; Bryan S; Macleod J; McCarthy A; Egger M; Sanford E; Low N;
Sex Transm Infect; 2007 Jul; 83(4):276-81. PubMed ID: 17229792
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of genital Chlamydia in Iranian males with urethritis attending clinics in Mashhad.
Ghanaat J; Afshari JT; Ghazvini K; Malvandi M
East Mediterr Health J; 2008; 14(6):1333-7. PubMed ID: 19161108
[TBL] [Abstract][Full Text] [Related]
20. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]